human
respiratori
syncyti
viru
hrsv
main
caus
bronchiol
pneumonia
among
infant
children
year
age
worldwid
major
caus
hospit
current
vaccin
avail
hrsv
antivir
treatment
limit
use
synagi
palivizumab
expens
human
monoclon
antibodi
use
prevent
treatment
ribavirin
nucleosid
antimetabolit
sever
toxicolog
liabil
use
except
circumst
therefor
urgent
need
discov
new
molecul
capabl
inhibit
rsv
replic
togeth
bovin
rsv
canin
pneumoviru
mice
hrsv
belong
genu
pneumoviru
famili
paramyxovirida
order
rsv
envelop
nonseg
negativestrand
rna
viru
genom
transcrib
subgenom
messeng
rna
mrna
encod
protein
includ
protein
nucleocapsid
n
p
l
attach
g
fusion
f
surfac
glycoprotein
major
neutral
protect
antigen
gene
order
genom
rsv
possess
singl
polymeras
entri
site
transcript
end
leader
region
transcript
gene
occur
sequenti
polar
fashion
thu
gradient
transcript
level
rsv
mrna
correl
distanc
promot
genom
gene
give
rise
greatest
amount
nonstructur
gene
first
transcrib
abund
gene
encod
protein
target
cellular
antivir
respons
thu
rapid
strong
express
crucial
viru
surviv
soon
rsv
nucleocapsid
penetr
cytoplasm
search
rsv
inhibitor
gener
base
labori
timeconsum
expens
method
gener
consist
analysi
cytopath
effect
microscopi
reduct
viru
replic
immunostain
plaqu
reduct
assay
quantit
revers
transcriptas
qrt
pcr
enzymelink
immunosorb
assay
test
reduct
rsvinduc
cell
cytotox
virus
modifi
genom
express
report
gene
code
green
fluoresc
protein
gfp
luciferas
suitabl
screen
coupl
use
autom
plate
reader
report
genecarri
recombin
virus
make
assay
suitabl
standard
highthroughput
purpos
infecti
recombin
hrsv
rhrsv
produc
intracellular
coexpress
transfect
plasmid
rsv
antigenom
rna
positivesens
replic
intermedi
genom
rna
togeth
n
p
l
model
hrsv
diseas
vivo
indispens
step
search
novel
therapi
prevent
measur
hrsv
diseas
far
method
monitor
cours
infect
rsv
real
time
live
anim
lack
common
experiment
nonprim
model
hrsv
infect
rodent
model
includ
inbr
balbc
mice
cotton
follow
hrsv
infect
viral
load
usual
peak
fourth
day
wane
eighth
day
viral
load
gener
estim
qrtpcr
use
rna
extract
homogen
lung
tissu
infect
anim
labori
time
consum
genet
engin
rsv
express
either
gfp
betagalactosidas
katushka
renilla
luciferas
foreign
gene
previous
howev
report
use
vivo
sever
recombin
virus
express
luciferas
gene
sendai
sindbi
dengu
vaccinia
herp
simplex
human
mous
influenza
engin
vivo
studi
previous
describ
engin
new
rhrsv
deriv
strain
long
express
either
firefli
luciferas
luc
mcherri
red
fluoresc
protein
use
tool
antivir
screen
combin
autom
fluoresc
plaqu
count
avoid
neg
effect
express
ns
gene
report
gene
place
p
gene
furthermor
report
visual
hrsv
infect
live
mice
use
rhrsv
carri
luc
report
gene
new
approach
realtim
studi
rsv
infect
evalu
antivir
therapeut
vivo
first
goal
engin
complementari
dna
cdna
copi
hrsv
genom
carri
uniqu
restrict
enzym
site
locat
intergen
region
facilit
manipul
rsv
genom
modif
individu
gene
addit
xhoi
bamhi
site
natur
present
end
sh
gene
begin
l
gene
respect
seven
uniqu
site
introduc
intergen
region
one
sali
variabl
region
eleven
segment
cover
entir
rsv
genom
individu
amplifi
clone
sequenti
assembl
lowcopi
fig
rna
polymeras
promot
place
upstream
leader
region
antigenom
rna
would
transcrib
three
supplementari
g
residu
end
hepat
delta
viru
hdv
antigenom
ribozym
sequenc
fuse
last
nucleotid
trailer
sequenc
achiev
correct
cleavag
develop
simpl
fast
highthroughput
antivir
assay
rsv
insert
gene
code
monomer
red
fluoresc
protein
mcherri
firefli
luciferas
luc
flank
rsv
gene
start
gene
end
signal
mlui
site
locat
p
gene
fig
recombin
rhrsvcherri
rhrsvluc
thu
express
one
addit
mrna
name
mcherri
luc
compar
rhrsv
plasmid
transfect
cell
along
four
plasmid
encod
n
p
l
protein
support
rsv
transcript
replic
previous
viabl
recombin
virus
recov
three
cdna
construct
multicycl
growth
compet
recombin
virus
passag
compar
wildtyp
wt
hrsv
shown
fig
growth
kinet
recombin
virus
significantli
differ
compar
wt
parent
hrsv
three
independ
experi
twoway
analysi
varianc
logarithmictransform
data
virus
maximum
titr
observ
h
post
infect
pi
titr
log
plaqu
form
unit
pfu
hsrv
long
strain
log
pfu
rhrsv
log
pfu
rhrsvmcherri
log
pfu
rhrsvluc
plaqu
phenotyp
parent
recombin
virus
shown
fig
appear
also
similar
plaqu
diamet
measur
signific
differ
observ
supplementari
tabl
mcherri
fluoresc
readili
detect
h
pi
cell
use
fluoresc
plate
reader
fig
fluoresc
microscop
fig
fluoresc
steadili
increas
h
h
fig
luciferas
activ
also
detect
extract
infect
cell
h
pi
fig
signaltonois
ratio
higher
luciferas
compar
mcherri
see
virus
present
cell
supernat
propag
three
passag
cell
express
mcherri
luc
report
shown
stabl
cours
eight
passag
thu
insert
mcherri
luc
report
gene
p
gene
major
impact
replic
capac
viru
establish
set
equip
requir
autom
plaqu
count
use
sever
dilut
rhrsvcherri
rhrsvluc
infect
cell
plate
autom
count
fluoresc
luminesc
done
differ
time
repres
data
shown
fig
curv
express
term
respons
rel
light
unit
rlu
rel
fluoresc
unit
logarithm
scale
versu
dose
pfu
per
well
logarithm
scale
demonstr
broad
linear
dynam
rang
pfu
per
well
rhrsvcherri
pfu
rhrsvluc
best
dynam
rang
observ
h
pi
rhrsvluc
rhrsvmcherri
fluoresc
signal
higher
h
pi
virus
signal
variabl
even
decreas
h
infect
probabl
due
viral
cytopath
effect
dynam
better
luc
compar
mcherri
linear
rlu
valu
extend
order
magnitud
strong
correl
viral
dose
luciferas
activ
result
inocula
pfu
per
well
plate
use
assay
rhrsvcherri
rhrsvluc
respect
fluoresc
luminesc
read
h
pi
h
pi
respect
arrow
fig
b
valid
rhrsvcherri
rhrsvluc
use
tool
highthroughput
antivir
screen
cell
infect
either
rhrsvcherri
rhrsvluc
presenc
rsv
l
polymeras
inhibitor
rsv
fusion
inhibitor
analogu
serial
dilut
inhibitor
ad
viral
inocula
incub
cell
luminesc
h
fluoresc
luciferas
mcherri
signal
measur
assess
inhibit
viral
replic
fluoresc
luminesc
signal
decreas
increas
rsv
inhibitor
concentr
wherea
control
dimethyl
sulfoxid
dmso
effect
fig
b
effect
compound
mcherri
express
rhrsvcherryinfect
cell
obviou
use
fluoresc
microscop
fig
measur
fluoresc
plate
reader
fig
reduct
luciferas
activ
fig
mcherri
fluoresc
fig
rhrsvluc
rhrsvcherryinfect
cell
treat
two
compound
allow
determin
half
maxim
effect
concentr
valu
inhibitor
observ
valu
nm
rhrsvcherri
nm
rhrsvluc
consist
nm
differ
hrsv
strain
infect
observ
valu
nm
rhrsvcherri
rhrsvluc
respect
similar
publish
nm
hrsv
strain
ref
compar
method
classic
method
also
determin
plaqu
reduct
assay
use
rhrsv
fig
observ
nm
respect
rang
determin
luminesc
fluoresc
assay
cytotox
concentr
valu
obtain
cell
much
higher
valu
recent
develop
highli
sensit
camera
enabl
use
luciferas
report
virus
vivo
imag
studi
viral
replic
spread
appli
approach
rsv
use
rhrsvluc
attempt
visual
rsv
replic
mous
model
balbc
mice
infect
report
viru
via
intranas
inocul
pfu
vivo
bioluminesc
intens
determin
daili
fig
mice
anaesthet
observ
aliv
use
ivi
imag
system
min
inject
dluciferin
compar
intraperiton
ip
inject
instil
luciferin
confer
one
two
order
magnitud
increas
luciferas
bioluminesc
detect
lung
supplementari
fig
weight
fig
temperatur
shown
anim
also
measur
sign
morbid
observ
bioluminesc
observ
respiratori
tract
detect
earli
dpi
snout
lung
rhrsvlucinfect
anim
maximum
bioluminesc
observ
dpi
snout
light
output
peak
day
lung
remain
detect
least
day
initi
infect
fig
bioluminesc
observ
mice
infect
wt
hrsv
fig
left
right
lung
equival
infect
supplementari
fig
remark
primoinfect
experi
long
strain
use
low
amount
rsv
infecti
particl
rsv
replic
clearli
visual
although
signific
weight
loss
clinic
sign
observ
either
wt
recombin
rhrsvluc
viru
verifi
rhrsvluc
replic
respiratori
tract
luciferas
activ
quantifi
either
isol
organ
organ
homogen
shown
supplementari
fig
bioluminesc
observ
isol
lung
liver
spleen
luciferas
activ
also
detect
lung
liver
spleen
homogen
determin
whether
direct
correl
bioluminesc
intens
viral
titr
lung
collect
lung
mice
day
pi
viral
load
measur
qrtpcr
compar
differ
virus
observ
good
correl
spearman
rel
viral
load
lung
bioluminesc
intens
valid
use
bioluminesc
marker
assess
viral
load
lung
mice
infect
rhrsvluc
fig
togeth
result
show
bioluminesc
imag
rhrsvlucinfect
mice
reflect
statu
pulmonari
infect
real
time
test
whether
rhrsvluc
use
vivo
assess
antivir
drug
administ
daili
singl
oral
dose
given
h
prior
inocul
viru
day
base
efficaci
dose
administr
rout
establish
compound
vivo
studi
wt
rsv
ref
mice
infect
pfu
rhrsvluc
vivo
bioluminesc
intens
determin
daili
fig
bioluminesc
strongli
reduc
respiratori
tract
mice
treat
photon
p
wherea
mice
receiv
drug
display
strong
bioluminesc
p
fig
low
signal
p
detect
mockinfect
mous
result
show
rhrsvluc
use
tool
vivo
evalu
drug
effici
rsv
use
mous
model
urgent
develop
antivir
drug
vaccin
rsv
although
sever
molecul
shown
inhibit
rsv
replic
vitro
review
ref
current
none
avail
commerci
drug
review
ref
due
least
part
cumbersom
screen
system
rsv
moreov
requir
biosafeti
level
confin
facil
develop
new
revers
genet
system
rsv
allow
easi
manipul
genom
introduc
enzym
restrict
site
along
cdna
intergen
region
construct
allow
easi
insert
report
gene
modif
individu
gene
two
recombin
rsv
virus
express
either
mcherri
red
fluoresc
protein
firefli
luciferas
report
deriv
construct
replic
rate
three
recombin
virus
togeth
wt
viru
long
strain
roughli
similar
show
presenc
foreign
mcherri
luc
gene
insert
p
transcript
unit
littl
effect
viru
replic
vitro
recombin
rsv
virus
express
gfp
betagalactosidas
katushka
r
luciferas
foreign
gene
previous
virus
report
gene
place
end
genom
first
gene
express
howev
van
remmerden
et
notic
rhrsv
egfp
gene
place
upstream
attenu
compar
construct
egfp
gene
locat
sh
g
wt
viru
similar
result
obtain
thu
like
insert
supplementari
gene
first
posit
detriment
growth
properti
rsv
decreas
delay
express
ns
gene
observ
construct
report
gene
express
shown
mirror
viral
replic
use
monitor
viral
growth
elimin
timeconsum
fixat
stain
step
well
manual
plaqu
count
use
report
gene
express
inhibit
found
valu
similar
determin
refer
method
recombin
virus
may
reliabl
tool
studi
antivir
drug
screen
well
advanc
character
recombin
advantag
disadvantag
autom
highthroughput
screen
rhrsvcherri
viru
requir
fluoresc
plate
reader
consum
except
plastic
dish
cell
cultur
media
hand
rhrsvluc
viru
requir
luminomet
reaction
substrat
luciferas
assay
thu
expens
also
sensit
accur
greater
dynam
rang
lower
background
rhrsvluc
readout
also
perform
store
frozen
plate
cell
lysi
sever
day
allow
batch
analys
may
also
coupl
cell
viabil
assay
relay
r
luciferas
activ
assess
drug
toxic
efficaci
assay
recombin
rsv
express
either
mcherri
firefli
luciferas
luc
two
advantag
report
construct
vitro
vivo
studi
first
background
red
fluoresc
gener
lower
green
fluoresc
particularli
organ
tissu
thu
rhrsvcherri
could
use
vivo
identif
target
cell
rsv
replic
lung
epitheli
cell
second
firefli
luc
allow
vivo
studi
shown
work
use
balbc
mous
model
chargecoupl
devic
camera
consum
rel
cheap
compar
r
luciferas
luc
activ
stabl
substrat
administ
nasal
rout
two
new
recombin
virus
could
constitut
use
complementari
tool
futur
screen
assay
inde
rhrsvcherri
could
conveni
first
step
highthroughput
screen
assay
wherea
rhrvluc
use
precis
determin
quantif
exact
level
rsv
replic
presenc
drug
recent
new
technolog
allow
realtim
track
cell
invas
rsv
cultur
cell
technolog
base
prior
rsv
surfac
label
biotin
revel
gold
nanoparticl
combin
streptavidin
use
darkfield
microscopi
sinc
goldlabel
rsv
particl
still
infecti
approach
well
adapt
studi
cell
invas
process
rsv
inhibit
drug
target
fusion
process
howev
contrast
recombin
virus
methodolog
appli
screen
drug
target
viral
polymeras
largescal
screen
vivo
studi
mous
popular
speci
experiment
model
hrsv
shown
recombin
viru
rhrsvluc
use
live
mice
monitor
viru
replic
use
noninvas
imag
techniqu
sinc
luminesc
detect
rhrsvlucinfect
mice
sinc
live
anim
monitor
differ
time
point
number
anim
need
collect
suffici
data
reduc
mice
per
experi
knowledg
first
report
vivo
imag
rsv
replic
rsv
replic
detect
snout
lung
live
mice
previous
sinc
use
infecti
particl
per
mous
usual
result
also
show
sensit
readout
rsv
replic
use
luc
assay
sinc
clinic
sign
moder
mice
experiment
infect
hrsv
lowtomoder
histopatholog
associ
moder
viral
replic
vivo
imag
techniqu
adapt
rsv
realli
power
practic
easi
use
approach
follow
rsv
replic
furthermor
allow
releas
labori
techniqu
qrtpcr
requir
anim
kill
shown
mice
infect
rhrsvluc
also
use
anim
model
test
antivir
drug
efficaci
interest
rsv
fusion
inhibitor
attenu
complet
block
rsv
replic
nasopharynx
mice
test
experi
condit
howev
suffici
stop
spread
rsv
nasopharynx
lung
mice
test
reach
goal
success
rsv
therapi
prevent
lowerrespiratori
tract
infect
result
highlight
potenti
evalu
rsv
treatment
window
antivir
target
point
intervent
efficaci
therapi
monitor
rsv
replic
kinet
time
cours
viru
spread
anim
use
noninvas
report
viru
system
conclus
new
tool
constitut
power
method
monitor
viral
replic
vivo
real
time
also
develop
new
therapeut
strategi
futur
challeng
improv
mous
model
increas
capac
recombin
rsv
replic
mice
andor
induc
clinic
sign
aim
could
address
slot
gene
rsv
strain
recent
isol
line
ref
memphi
ref
adapt
test
vaccin
aim
protect
current
circul
strain
rsv
studi
carri
accord
inra
guidelin
complianc
european
anim
welfar
regul
protocol
approv
anim
care
use
committe
centr
de
recherch
de
jouyenjosa
comethea
protocol
number
relev
institut
author
direct
de
la
protect
de
popul
de
yvelin
permit
number
experiment
procedur
perform
biosafeti
level
facil
atcc
number
ref
cell
maintain
eagl
minimum
essenti
medium
dulbecco
modifi
eagl
medium
respect
supplement
fetal
calf
serum
mm
lglutamin
solut
cell
grown
incub
cytotox
assay
done
celltiterglo
luminesc
cell
viabil
assay
promega
h
incub
compound
construct
fulllength
cdna
clone
hrsv
subgroup
strain
long
genbank
access
noncut
enzym
kpni
bspei
mlui
stui
bsteii
sali
bstbi
uniqu
cut
enzym
xhoi
bamhi
hrsv
cdna
identifi
polylink
contain
design
restrict
site
downstream
hdv
ribozym
sequenc
follow
transcript
termin
upstream
promot
insert
lowcopi
vector
ref
kind
gift
dr
jonduri
tratschin
institut
virolog
immunoprophylaxi
switzerland
smai
restrict
site
randomprim
cdna
synthesi
done
use
superscriptii
gibcobrl
total
cytoplasm
rna
isol
cell
infect
human
rsv
subgroup
long
strain
atcc
pcr
perform
cdna
use
highfidel
pfu
ultra
polymeras
stratagen
specif
primer
tabl
amplifi
fragment
cover
whole
rsv
genom
genbank
access
use
standard
procedur
complet
hrsv
genom
sequenc
use
two
independ
pcr
product
fragment
use
refer
bamhi
bstbi
restrict
site
present
g
cdna
sequenc
hrsv
strain
destroy
sitedirect
mutagenesi
without
modifi
aminoacid
sequenc
kpni
bspei
mlui
stui
bsteii
sali
restrict
site
absent
hrsv
cdna
place
np
pm
intergen
region
respect
uniqu
sacii
bstbi
site
introduc
leader
trailer
sequenc
respect
uniqu
sali
site
place
variabl
region
sacii
site
destroy
thereaft
sitedirect
mutagenesi
construct
fulllength
hrsv
cdna
clone
result
total
nucleotid
chang
intergen
region
amplifi
fragment
clone
separ
vector
fermenta
sequenc
verifi
antigenom
cdna
span
entir
hrsv
genom
assembl
singl
molecul
sequenti
ligat
rsv
cdna
fragment
vector
standard
subclon
techniqu
leader
end
construct
abut
promot
rna
polymeras
trailer
end
construct
adjac
autocatalyt
hdv
ribozym
sequenc
result
vector
gener
posit
sens
antigenom
rna
transcript
three
addit
g
residu
terminu
leav
exact
nativ
terminu
posit
sequenc
alter
due
restrict
site
insert
list
tabl
firefli
luciferas
luc
mcherri
gene
amplifi
pcr
use
specif
primer
forward
revers
primer
tabl
first
flank
rsv
gene
start
gene
end
sequenc
hrsv
p
n
gene
respect
contain
mlui
restrict
site
end
enabl
insert
gene
unit
vector
construct
verifi
sequenc
revers
genet
vector
cotransfect
togeth
express
vector
pn
pp
pl
control
subconflu
cell
monolay
dish
use
fugen
hd
promega
reagent
accord
manufactur
recommend
viru
collect
h
post
transfect
titrat
plaqu
assay
assess
viru
rescu
effici
recombin
virus
amplifi
fresh
cell
low
multipl
infect
pfu
per
cell
day
rtpcr
perform
passag
verifi
presenc
mlui
restrict
site
pm
intergen
region
rhrsv
viru
stock
frozen
passag
virus
titrat
cell
use
plaqu
assay
procedur
adapt
matrosovitch
et
brief
cell
infect
serial
dilut
viral
suspens
complet
minimum
essenti
medium
mem
overlay
prepar
microcrystallin
cellulos
avicel
fmc
biopolym
final
concentr
complet
mem
contain
fetal
calf
serum
day
plaqu
reveal
crystal
ethanol
solut
stain
cell
layer
number
pfu
per
well
count
nake
eye
cell
seed
cell
per
well
plate
day
infect
serial
threefolddilut
viral
suspens
begin
pfu
per
well
mcherri
assay
mem
without
phenol
red
gibco
use
cell
cultur
viru
dilut
luciferas
assay
infect
cell
incub
h
wash
phosphatebuff
salin
pb
lysi
lysi
buffer
mm
tri
ph
mm
triton
glycerol
mm
dithiothreitol
per
well
min
room
temperatur
gentl
shake
plate
substrat
equilibr
luciferas
activ
measur
express
rlu
use
tecan
infinit
plate
reader
automat
inject
deliv
dluciferin
sigma
atp
mm
lysi
buffer
mcherri
fluoresc
measur
infect
cell
incub
h
fluoresc
could
observ
fluoresc
microscop
measur
use
spectrofluoromet
tecan
infinit
excit
emiss
wavelength
nm
respect
express
rel
fluoresc
unit
noninfect
cell
use
standard
fluoresc
luminesc
background
level
plaqu
reduct
assay
rhrsvcherri
viru
grown
cell
presenc
serial
threefold
dilut
rsv
polymeras
inhibitor
ref
nm
rsv
fusion
inhibitor
analogu
ref
nm
plaqu
count
use
plaqu
assay
protocol
describ
plaqu
number
plot
compound
concentr
graphic
determin
inhibitor
concentr
induc
reduct
plaqu
number
cell
seed
cell
per
well
plate
day
infect
pfu
rsvluc
rsvmcherri
respect
presenc
variou
drug
concentr
compound
solubil
mm
vv
dmso
dilut
water
mm
serial
dilut
threefold
mem
without
phenol
red
medium
final
concentr
nm
nm
nm
dmso
dilut
rang
also
use
control
compound
dilut
preincub
viral
suspens
min
addit
cell
monolay
plate
plate
incub
h
rhrsvluc
h
rhrsvcherri
luciferas
assay
mcherri
fluoresc
measur
perform
describ
luminesc
read
fluoresc
read
express
percentag
mean
control
valu
well
infect
without
drug
calcul
fit
data
sigmoid
curv
equat
use
algorithm
provid
commerci
avail
kaleidagraph
softwar
packag
synergi
softwar
femal
balbc
mice
purchas
centr
delevag
r
janvier
le
genest
saintisl
franc
use
around
week
age
mice
strain
bred
pathogenfre
anim
facil
mice
fed
normal
mous
chow
water
ad
libitum
rais
hous
standard
condit
air
filtrat
infect
experi
mice
hous
cage
insid
stainless
steel
isol
cabinet
ventil
neg
pressur
higheffici
particul
airfilt
air
mice
anesthet
mixtur
ketamin
xylazin
mg
per
mous
respect
infect
pb
contain
pfu
rhrsvluc
bodi
weight
monitor
day
vivo
imag
mice
anesthet
altern
mice
kill
differ
time
point
lung
collect
time
point
experi
done
triplic
antivir
drug
administr
anim
dissolv
steril
water
mg
solut
adjust
ph
hcl
n
previous
anim
treat
ml
dissolv
deliv
oral
gavag
oral
treatment
administ
h
prior
rsv
inocul
daili
viral
load
measur
lung
homogen
qrtpcr
briefli
lung
crush
total
rna
extract
lung
homogen
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
four
individu
rna
sampl
revers
transcrib
h
use
u
mmlv
revers
transcriptas
superscript
ii
invitrogen
random
hexanucleotid
primer
pd
n
pharmacia
biotech
nmol
deoxynucleotid
triphosph
mm
dithiothreitol
u
ribonucleas
inhibitor
rnaseout
invitrogen
accord
manufactur
instruct
primer
aliquot
store
frozen
solut
use
target
either
hrsv
n
gene
murin
hprt
gene
follow
sequenc
n
forward
primer
agatcaacttctgtcatccagcaa
n
revers
primer
ttctgcacatcataattaggagtatcaat
hprt
forward
primer
caggccagactttgttggat
hprt
revers
primer
ttgcgctcatcttaggcttt
individu
cdna
mix
sybr
green
pcr
master
mix
life
technolog
primer
target
n
gene
primer
target
murin
hprt
gene
realtim
pcr
run
micropl
realplex
mastercycl
eppendorf
determin
viral
load
individu
cdna
dilut
rnasefre
water
mix
sybr
green
pcr
master
mix
appli
biosystem
contain
nm
n
primer
nm
hprt
primer
triplic
gene
nontempl
control
run
assay
fluoresc
curv
analys
use
realplex
mastercycl
sequenc
detector
eppendorf
determin
cycl
threshold
ct
valu
gene
individu
data
normal
hprt
calcul
valu
ct
n
hprt
median
rel
quantiti
n
transcript
normal
hprt
express
au
mice
anaesthet
luminesc
measur
min
ip
inject
pb
contain
dluciferin
sigma
use
mg
mg
ip
rout
photon
emiss
mockinfect
rhrsvlucinfect
mice
pfu
per
mous
measur
use
ivi
imag
system
xenogen
corp
live
imag
softwar
version
calip
life
scienc
use
measur
luciferas
activ
bioluminesc
imag
acquir
min
digit
falsecolour
photon
emiss
imag
mous
gener
photon
count
within
constant
region
interest
correspond
surfac
chest
encompass
wholeairway
area
photon
emiss
measur
radianc
p
cite
articl
rameixwelti
et
al
visual
replic
respiratori
syncyti
viru
cell
live
mice
nat
commun
doi
access
code
nucleotid
sequenc
rhrsv
rhrsvluc
rhrsvcherri
deposit
genbank
nucleotid
databas
access
code
